Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL31P12 is a processed pseudogene of the ribosomal protein L31 gene family in humans. It does not encode a functional protein and is not associated with a known biological function, disease role, or drug interaction. Pseudogenes like RPL31P12 are remnants of genes that have lost their protein-coding potential, often through mutations or genomic rearrangements. Unlike the functional RPL31 gene, which participates in assembling the 60S ribosomal subunit involved in protein synthesis, RPL31P12 has no demonstrated role in ribosome function or biomedically relevant pathways[1][2][7]. It is not a functional gene product and is not considered a therapeutic target or receptor. There is no evidence for involvement in disease, drug interaction, or biomarker applications in the current literature[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 12 (RPL31P12).